Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0003 USD
Change Today +0.0002 / 200.00%
Volume 8.6M
HPNN On Other Exchanges
As of 3:59 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

hop-on inc (HPNN) Key Developments

Hop-on Staffs New Office in Shenzhen, China

Hop-On Inc. announce that a new office has been opened in Shenzhen, China with support staff in response to the overwhelming business opportunities for products being produced and shipped to US and European markets under Hop-on's intellectual property rights. The new office is located at Room 308, BLD A, Unisplendour Information Harbor, Hi-Tech Park North, Nan Shan District, Shenzhen, Guangdong, China, 51800.

Hop-on and United Cannabis Sign Contract

Hop-on Inc. announced that an agreement has been reached with United Cannabis Corporation Inc. to assist with a regional rollout in the multibillion dollar Cannabis market utilizing their licensed partners' prolific catalog of CBD-dominant and THC:CBD strains and world class cultivation expertise. UCANN was selected as a strategic partner for their expertise in the medical and recreational Cannabis marketplace, their numerous regional partners that are state licensed and have been vetted for quality, consistency, and business ethics, and the fact that they are actively expanding from Colorado to other markets as they become viable. UCANN will assist in provisioning exclusive Cannabis cultivars that meet the stringent needs of Re-Medical's standardized cannabinoid profiles, and provide assistance in the build-out of processing, extraction, and production facilities, and regional sales and distribution operations for Re-Medical's cannabinoid therapies. Re-Medical will provide licensing of intellectual property, where appropriate, regarding standardized cannabinoid profiles that show empirical or clinical efficacy as treatment for specific ailments, standardized cannabinoid profile extraction methods, efficient extraction of active ingredients from Cannabis using supercritical CO2 fluid extraction technologies, and the formulation and fabrication of transdermal and other innovative cannabinoid delivery technologies. The market for CBD and other cannabinoid therapies is just beginning to be tapped, with over $600 million in annual sales expected this year in Colorado alone. With the entrance of more regions into the self-regulated cannabis marketplace, and the use of curated strains, professional production and processing methods, and rigorous testing standards, the market currently valued at $1.53 billion is projected to grow 68% to $2.57 billion by the end of 2014.

Hop-On Inc., Special/Extraordinary Shareholders Meeting, May 16, 2014

Hop-On Inc., Special/Extraordinary Shareholders Meeting, May 16, 2014., at 10:00 Pacific Standard Time. Location: Embassy Suites Hotel located at 2121 Main Street. Agenda: To consider progress on becoming fully reporting in anticipation of potential mergers; to consider updates on the licensing of IP rights under the Microsoft agreement; to consider the benefits of working with Chinese OEMs and ODMs; to consider discussion of the benefits of retiring several million dollars of debt of the company in creating shareholder value; to consider plans and status of the roll out of its CBD and THC Patches in legal jurisdictions using State, National and International Distribution; and to consider efforts to distribute USAcig hardware utilizing THC/CBD oil from CO2 extraction methods.

Hop-On Inc. Signs Contract with Teleepoch, Ltd

Hop-On Inc. announced that Hop-on and Teleepoch, Ltd. have agreed to terms regarding manufacturing, distribution, and intellectual property royalties under Hop-on's agreement with Microsoft. Teleepoch has agreed to an upfront fee in the six figure range. Other contract terms between Hop-on and Teleepoch remain confidential. Hop-on is actively perusing ODMs and OEMs of smartphones, tablets, televisions, set-top boxes, eReaders, portable navigation devices, and the like that can benefit from Hop-on's license agreements to essential patents for devices running the Android and Chrome OS.

Hop-On Inc. Signs Letter of Intent with Chinese Manufacturer

Hop-On Inc. announced that it has a signed Letter of Intent with a Chinese Manufacturer anticipating $100,000,000 in revenue under the IPR enjoyed by the company. This Letter of Intent calls for an initial payment of $150,000; ongoing intellectual property royalties in accordance with the Company's IP agreements; and the distribution of this Chinese manufacturer's products, initially a smartphone, in the United States and Europe, under the Hop-on brand.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HPNN:US $0.00 USD +0.0002

HPNN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HPNN.
View Industry Companies

Industry Analysis


Industry Average

Valuation HPNN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOP-ON INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at